Global Flexible Manufacturing Systems in the Pharmaceutical Industry Market (2021 to 2026) - Rising Opportunities with Industry 4.0 and Pharma 4.0
26 oct. 2021 07h23 HE
|
Research and Markets
Dublin, Oct. 26, 2021 (GLOBE NEWSWIRE) -- The "Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry" report has been added to ResearchAndMarkets.com's offering. This...
Josh Wilhelm Joins PetVivo Holdings, Inc. as the Director of Manufacturing
08 sept. 2021 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Sept. 08, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative...
Psychedelic Joint Venture Between Mycotopia Therapies and Natural MedTech Brings Research and Drug Development to Test Active Ingredient In Psychedelics
22 mars 2021 07h00 HE
|
20/20 Global, Inc.
MIAMI, March 22, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc. dba Mycotopia Therapies, (OTC Pink: TWGL) (the “Company”), a company focused on psychedelic therapies, announced today it has formed...
Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing
08 mars 2021 03h00 HE
|
Cytovance Biologics
OKLAHOMA CITY, March 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Cytovance Biologics offers Nature Technology Corporation’s proprietary HyperGRO™ manufacturing platform for plasmid DNA CGMP manufacturing
30 nov. 2020 03h00 HE
|
Cytovance Biologics
OKLAHOMA CITY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Provectus Biopharmaceuticals Highlights Stage IV M1c Patient Outcome from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Naïve Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020
21 sept. 2020 12h45 HE
|
Provectus Biopharmaceuticals Inc.
Near-resolution of tumor burden, including extensive visceral hepatic diseaseExpanded data set of trial subject provided KNOXVILLE, TN, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT)...
Global CDMO Industry Insights Report 2019-2025: Market Size Breakdown by Type of Service, Type of Molecule, End Use and Region
02 sept. 2020 05h19 HE
|
Research and Markets
Dublin, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The "Global Market Opportunities and Competitive Landscape for CDMO" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Provectus Biopharmaceuticals Expands Sponsored Research Collaboration with University of Calgary (Canada) to Investigate Oral Administration of Rose Bengal Disodium for Cancer Treatment
13 août 2020 08h00 HE
|
Provectus Biopharmaceuticals Inc.
University of Calgary researchers have successfully demonstrated initial, in vivo proof-of-concept, oral rose bengal disodium treatment for blood cancerResearchers will now investigate oral treatment...
Open Book Extracts Enters South Africa Market with Strategic Distribution Partner, Strengthening Global Reach
31 juil. 2020 08h33 HE
|
Open Book Extracts
ROXBORO, N.C., July 31, 2020 (GLOBE NEWSWIRE) -- With demand increasing for quality, high-purity cannabinoid ingredients like CBD, THCV and CBN globally, leading cannabinoid-based health and...
Cytovance Biologics Announces an Investment in Mass Spectrometry Services
15 juil. 2020 03h00 HE
|
Cytovance Biologics
OKLAHOMA CITY, July 15, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the addition of Mass...